Work

Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Non-Advanced Systemic Mastocytosis

Year: 2026
Type: article
Institutions: Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Duke University, Duke Cancer Institute, The University of Texas MD Anderson Cancer Center, Antwerp University Hospital, University of Basel, University Hospital of Basel, University of Michigan, Huntsman Cancer Institute, ARUP Laboratories (United States), Mayo Clinic in Arizona, University Medical Center Groningen, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, St. Thomas Hospital, University Medical Centre Mannheim, Hospital Universitario Ramón y Cajal, Oslo University Hospital, Universitätsklinikum Aachen, RWTH Aachen University, Washington University in St. Louis, University of Alabama at Birmingham, Emory University, Brigham and Women's Hospital, Centre Hospitalier Universitaire de Toulouse, Hôpital Larrey, Erasmus MC, Hospital Virgen del Valle, The Ohio State University, University of Alberta, University of Calgary, University Clinical Centre, Medical University of Lublin, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco", Vanderbilt University Medical Center, Dartmouth Health, Dartmouth Cancer Center, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Institut Català d'Oncologia, Ospedale "Santa Maria delle Croci" di Ravenna, Azienda Unità Sanitaria Locale Della Romagna, Rush University Medical Center, Cogent Biosciences (United States), Charité – Universitätsmedizin Berlin, Dana-Farber Cancer Institute
Language: English
Subfield: Immunology
Open Access status: bronze
OpenAlex ID: W7128481073
FWCI:
Cites:
Cited by:
Related to: 10